Anuh Pharma P/E Ratio
Current P/E Ratio
19.89
Moderate Valuation
Moderate - Fairly valued
Anuh Pharma P/E ratio. Anuh Pharma (ANUHPHR) P/E ratio is 19.89 (Moderate), EPS (TTM) ₹4.10, current price ₹84.15 on NSE — Moderate - Fairly valued. For live price, revenue and the complete fundamental profile, see ANUHPHR stock price BSE.
Current Valuation Metrics
P/E Ratio
19.89
Current Price
₹84.15
EPS (TTM)
₹4.10
Exchange
NSE
Valuation Signal
Signal
Fairly Valued
Sector Context
Sector Average
56.38
Sector Median
32.5
Sector Rank
#11 of 199
Sector Percentile
5.5%
ANUHPHR P/E Ratio — Valuation Signal & Historical Context
Anuh Pharma P/E 19.89 — signal: Fairly Valued. Also explore ANUHPHR share price data to track price trends across different timeframes.
- Trading at discount to sector average PE of 56.38
ANUHPHR vs Healthcare Peers — P/E Ratio Comparison
Anuh Pharma P/E 19.89 vs Healthcare average 56.38, median 32.5 — range 2.04–740.29.
Sector Average
56.38
Sector Median
32.5
Lowest P/E
2.04
Highest P/E
740.29
Companies
199
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Sunrest Lifescience | SUNREST | 2.04 | ₹65 | Low |
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Phaarmasia | PHRMASI | 3.41 | ₹63 | Low |
| Sun Pharma Advanced Rese… | SPARC | 3.98 | ₹6,206 | Low |
| Dipna Pharmachem | DPL | 4.57 | ₹12 | Low |
| JFL Life Sciences | JFLLIFE | 4.88 | ₹66 | Low |
| GKB Ophthalmics | GKB | 5.88 | ₹32 | Low |
| Kabra Drugs | KABRADG | 6.09 | ₹44 | Low |
| Royal Sense | ROYAL | 6.58 | ₹47 | Low |
| Colinz Laboratories | COLINZ | 6.62 | ₹18 | Low |